10x Genomics Inc. Revenue 2017–2025
10x Genomics Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- 10x Genomics Inc. revenue for the quarter ending March 31, 2026 was 150.8 M, a 2.61% decrease year-over-year.
- 10x Genomics Inc. revenue for the twelve months ending March 31, 2026 was 627.6 M, a 4.71% increase year-over-year.
- 10x Genomics Inc. annual revenue for 2025 was 642.8 M, a 5.25% increase from 2024.
- 10x Genomics Inc. annual revenue for 2024 was 610.8 M, a 1.28% decrease from 2023.
- 10x Genomics Inc. annual revenue for 2023 was 618.7 M, a 19.81% increase from 2022.
- 10x Genomics Inc. annual revenue for 2022 was 516.4 M.
10x Genomics Inc. (TXG) — Frequently Asked Questions
10x Genomics Inc. (TXG) is a publicly traded US company. It has a market capitalization of $3.54B. In fiscal 2025 it reported revenue of $643M and net income of -$44M. Explore TXG's stock price, financial statements, earnings history, margins and key ratios below.
What is 10x Genomics Inc.'s market cap?
10x Genomics Inc. (TXG) has a market capitalization of $3.54B.
What is the TXG stock price?
TXG trades at $28.38 (-2.51% on the day).
How much revenue does 10x Genomics Inc. make?
10x Genomics Inc. reported revenue of $643M in fiscal 2025.
Is TXG profitable?
In fiscal 2025, 10x Genomics Inc. reported net income of -$44M.